Samantha Eileen Kolb, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1360 Elm St E, Saint Joseph, MN 56374 Phone: 320-363-7765 |
Emily J Rath, RN, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 37 S. College Ave, Saint Joseph, MN 56374 Phone: 320-363-5605 |
Mrs. Carol L Holton, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 37 College Ave South, Saint Joseph, MN 56374 Phone: 320-363-5605 Fax: 320-363-6396 |
Mrs. Taylor Lynne Ricke, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1360 Elm St E, Saint Joseph, MN 56374 Phone: 320-363-7765 |
Nancy Streng, P/MHNP Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9213 Narcissus Rd, Saint Joseph, MN 56374 Phone: 320-363-0385 |
Susan A. Heying, RN, CFNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1360 Elm St E, Saint Joseph, MN 56374 Phone: 320-363-1745 Fax: 320-363-0031 |
News Archive
The web site of South Korea's new stem cell bank has crashed even before it began taking applications to take part in research.
In the early 1990s, drug production in Colombia diversified to include heroin as well as cocaine, and since then the country's role in the heroin trade has substantially increased. According to the United Nations Office on Drugs and Crime, Colombia produced approximately 70 to 100 metric tons of heroin between 1998 and 2004. Studies have found an increase in local heroin use since the mid-1990s. This is a strong cause for concern, given the potential for HIV to spread through networks of injection drug users and disseminate to the general public.
Twenty to 50 percent of Americans suffer from acute insomnia each year, defined as difficulty falling asleep or staying asleep, three or more nights per week, for between two weeks and three months.
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.
› Verified 2 days ago